Vishal Vashistha

7PUBLICATIONS
12CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisCancer geneticsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 17, 2023
Real-world Experience With Neurotrophic Tyrosine Receptor Kinase Fusion-positive Tumors and Tropomyosin Receptor Kinase Inhibitors in Veterans.

Katherine I Zhou, Vishal Vashistha, Aixia Guo

|Feb 22, 2023
Health outcomes and healthcare resource utilization among Veterans with stage IV non-small cell lung cancer treated with second-line chemotherapy versus immunotherapy.

Christina D Williams, Mina A Allo, Lin Gu

|Feb 14, 2023
Molecular-Guided Off-Label Targeted Therapy in a Large-Scale Precision Oncology Program.

Vishal Vashistha, Evangelia Katsoulakis, Aixia Guo

|Jun 06, 2022
Evaluation of delays during diagnosis and management of lung cancer in India: A prospective observational study.

Avneet Garg, Hariharan Iyer, Vinita Jindal

|May 31, 2022
Prevalence of highly actionable mutations among Indian patients with advanced non-small cell lung cancer: A systematic review and meta-analysis.

Ruchir Raman, Varun Ramamohan, Anurag Rathore

|Apr 27, 2022
Homologous Recombination Repair Gene Variants and Outcomes Among Patients With Prostate Cancer Treated With Poly (ADP-ribose) Polymerase Inhibitors.

Meghan J Price, Vishal Vashistha, David Winski

Pageof 2

Frequent Collaborators

4 joint publications

Michael J Kelley

2 joint publications

Meghan Price

1 joint publications

Pradeep J Poonnen

1 joint publications

Bradley Hintze